19
Clinical Trials associated with Umbilical Cord Mesenchymal Stem Cells(Sun Yat-Sen University)Mesenchymal Stem Cell for Treatment of Chronic Graft-versus-host Disease After Allogenetic Hematopoietic Stem Cell Transplantation
The purpose of this study is to evaluate the efficacy of mesenchymal stem cells in patients with chronic graft-versus-host disease.
Mesenchymal Stromal Cell-based Therapy for COVID-19-associated Acute Respiratory Distress Syndrome: a Pilot Clinical Study
Considering the potential of mesenchymal stromal cells (MSCs) in the treatment of lung injuries by COVID-19, this pilot clinical trial evaluates the safety and potential efficacy of the cell therapy, administered intravenously, in patients with pneumonia associated with COVID-19-associated acute respiratory distress syndrome.
Human Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Acute Respiratory Distress Syndrome
Acute respiratory distress syndrome (ARDS) is a devastating inflammatory and destructive disease in critical ill patients. Preclinical studies have shown a promising perspective of mesenchymal stem cells (MSCs) therapies in ARDS. But the safety and efficacy of umbilical cord MSCs (UCMSCs) have not yet been convinced in clinical trails. This study will explore the safety and life-rescue potential of UCMSCs in refracotry ARDS.
100 Clinical Results associated with Umbilical Cord Mesenchymal Stem Cells(Sun Yat-Sen University)
100 Translational Medicine associated with Umbilical Cord Mesenchymal Stem Cells(Sun Yat-Sen University)
100 Patents (Medical) associated with Umbilical Cord Mesenchymal Stem Cells(Sun Yat-Sen University)
100 Deals associated with Umbilical Cord Mesenchymal Stem Cells(Sun Yat-Sen University)